AI assistant
Citadel Group M&A Activity 2021
10454_mrq_2021-01-04_eae3a320-70df-43d8-aed8-ede40d116db4.html
M&A Activity
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 4653K
Citadel Group
04 January 2021
Ap 19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Citadel Group |
| Company dealt in | WILLIS TOWERS WATSON PLC |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | Common Stock ISIN IE00BDB6Q211 |
| Date of dealing | 31 December, 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
| Long | Short | |
| ISIN IE00BDB6Q211 | Number (%) | Number (%) |
| (1) Relevant securities | 190,085 (0.15%) | 0 (0.00%) |
| (2) Derivatives (other than options) | 1,728,325 (1.34%) | 0 (0.00%) |
| (3) Options and agreements to purchase/sell | 0 (0.00%) | 0 (0.00%) |
| Total | 1,918,410 (1.49%) | 0 (0.00%) |
Ap 20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale ISIN IE00BDB6Q211 |
Number of securities | Price per unit (Note 5) |
| Buy Transaction | 100 | 208.6400 USD |
| Buy Transaction | 200 | 208.6500 USD |
| Buy Transaction | 207 | 208.7161 USD |
| Buy Transaction | 30 | 208.8400 USD |
| Buy Transaction | 200 | 208.8500 USD |
| Buy Transaction | 22 | 208.8582 USD |
| Buy Transaction | 200 | 208.8600 USD |
| Buy Transaction | 188 | 208.8840 USD |
| Buy Transaction | 92 | 208.9000 USD |
| Buy Transaction | 348 | 208.9912 USD |
| Buy Transaction | 30 | 209.0033 USD |
| Buy Transaction | 297 | 209.2581 USD |
| Buy Transaction | 630 | 209.3366 USD |
| Buy Transaction | 442 | 209.5990 USD |
| Buy Transaction | 769 | 209.7773 USD |
| Buy Transaction | 558 | 209.9770 USD |
| Buy Transaction | 111 | 210.0673 USD |
| Buy Transaction | 977 | 210.4773 USD |
| Buy Transaction | 631 | 210.5154 USD |
| Buy Transaction | 100 | 210.5700 USD |
| Buy Transaction | 90 | 210.7500 USD |
| Buy Transaction | 26 | 210.9615 USD |
| Sell Transaction | 34 | 207.7012 USD |
| Sell Transaction | 1 | 207.7600 USD |
| Sell Transaction | 72 | 207.7600 USD |
| Sell Transaction | 981 | 208.6682 USD |
| Sell Transaction | 502 | 208.8349 USD |
| Sell Transaction | 80 | 208.9900 USD |
| Sell Transaction | 398 | 209.6538 USD |
| Sell Transaction | 100 | 209.6900 USD |
| Sell Transaction | 240 | 209.8727 USD |
| Sell Transaction | 196 | 210.6800 USD |
| Sell Transaction | 2,660 | 210.6800 USD |
| Sell Transaction | 400 | 210.7200 USD |
| Sell Transaction | 129 | 210.7668 USD |
| Sell Transaction | 105 | 211.0876 USD |
| Sell Transaction | 39 | 211.3154 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD ISIN IE00BDB6Q211 |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option | Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. |
Expiry date | Option money paid/ received per unit (Note 5) |
(ii) Exercising
| Product name, e.g. call option |
Number of securities | Exercise price per unit (Note 5) |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) |
Details | Price per unit (if applicable) (Note 5) |
Ap 21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated |
| None |
Is a Supplemental Form 8 attached? (Note 9)
NO
| Date of disclosure: | 04 January, 2021 |
| Contact name: | Kim Heslop |
| Telephone number: | 020 7645 9700 |
| If a connected EFM, name of offeree/offeror with which connected | n/a |
| If a connected EFM, state nature of connection (Note 10) | n/a |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ISEUPUWPGUPGGPC